Vinc was created in order to help companies active in the life sciences industry execute transformational transactions. Through all phases: pre-transaction, transaction, post-transaction. From start-ups to international corporations. With a 100% life sciences focus and our dedication to solution orientation, we speak the same language as our clients and act not only as service provider, we become a sparring partner.
Therefore we combine independent strategy consulting and financial advisory – Strategic Transaction Advisory.
With Vinc’s holistic advisory approach, we excel in tailor-made and solution oriented project execution, helping our clients to overcome their most challenging issues.
Vinc is a leading advisor in sale and carve-out preparation, exit readiness, commercial DD, company and plant sales and acquisitions, joint ventures and strategic alliances, post-merger strategy, buy&build and divestments.
We help our clients with tailor-made financial structuring, valuation and fairness opinions, defense strategies, debt financings, equity capital market transactions, project financings, recapitalizations, fundraisings.
Vinc executes international pre-commercial and commercial-stage licensing transactions, product and product portfolio sales and acquisitions, R&D/patent sales and acquisitions, as well as royalty monetization transactions.
We provide independent, special advisory services to company management, shareholders and executive committees with respect to value creation topics, M&A strategies, growth and market entry strategies as well as shareholder relations.
Customers from all over the world trust our competence in managing the sale and acquisition of companies, products and product portfolios, strategic advice, structuring financings and executing licensing as well as royalty monetization transactions. And we’re there for them, wherever they need us.
“We were very pleased with the support from Vinc during the entire process of the sale of our business. We really welcome the opportunity of the GBA Laboratory Group moving the company forward to the
next stages of its growth. Vinc has done a great job. Many thanks for getting what we believe was the best outcome of this transaction.“
Dr. Christine Batzl-Hartmann – CEO and founder of Pharmacelsus, DE
“The Vinc Team has been one of the very few amongst the advisory firms to demonstrate an intimate understanding of our CDMO industry, thus clearly standing out. Their expertise is clear and precious and their approach is professional and pragmatic, clearly going the extra mile to bring value.”
European Top 10 Drug Product CDMO – Head of Corporate Development
“We experienced Vinc to be a highly knowledgeable partner who advised us throughout the transaction process. We highly appreciated their full service: they helped us in many ways from company presentation support over deal negotiation to contract making. Our sincere appreciation to the dedicated team for their professionalism and perseverance.”
Dr. Harry Christiaens – CEO and shareholder Pharmavize, BE
“It was a pleasure working with the team of Vinc - on the other side(!). Vinc is a very professional organization with in-depth industry expertise – top league for mid-market transactions – and have clearly helped the sellers in the best way.”
Gijs Botman – Managing Partner Mentha